Your trusted destination for CME, CPD & Medical Education across the Middle East.
Conception
Matt Krisiloff is an American biotechnology entrepreneur, startup investor, and technology executive whose work focuses on reproductive biology, fertility research, and the development of innovative scientific technologies. He is best known as the Chief Executive Officer of Conception, a biotechnology company researching the development of human egg cells from induced pluripotent stem cells.
Krisiloff studied at the University of Chicago, where he developed an interest in technology, entrepreneurship, and scientific innovation. He began his professional career in the technology startup ecosystem and became involved with Y Combinator, one of the leading startup accelerators in the United States.
He later served as Director of Y Combinator Research and was a founding team member of OpenAI, contributing to the early development of the organization.
Krisiloff subsequently shifted his focus toward biotechnology and reproductive science. He co-founded Conception, a research company based in Berkeley, California, with the goal of developing techniques to transform human induced pluripotent stem cells into mature egg cells. This research could potentially open new possibilities in reproductive medicine, fertility treatment, and the understanding of human development.
As CEO, he leads the company's strategic direction, scientific development, and organizational growth. His work brings together scientific researchers, biotechnology specialists, and investors to address complex challenges in reproductive biology.
He is also a co-founder and partner at SciFounders, a venture capital firm supporting scientist-led biotechnology and healthcare startups. Through this work, he helps early-stage founders develop companies based on promising scientific discoveries.
In addition, Krisiloff is associated with Preventive, a biotechnology initiative exploring gene-editing approaches to prevent inherited genetic diseases.

dmg events
dmg events